佳力圖(603912.SH):定增募資額擬由不超9.94億元調至不超9.16億元
格隆匯8月4日丨佳力圖(603912.SH)公佈,根據《證券法》、《上市公司證券發行管理辦法》等法律法規的有關規定,結合市場環境的變化和公司實際情況,根據2021年第一次臨時股東大會授權,公司於2021年8月4日召開第二屆董事會第三十一次會議,審議通過了《關於調整公司2021年度非公開發行股票方案的議案》等關於公司此次非公開發行股票的相關議案,將此次非公開發行股票募集資金總額由不超過9.94億元調減為不超過91579萬元。此次非公開發行股票方案尚需中國證監會核准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.